Literature DB >> 2304137

Class I H-2d-restricted cytotoxic T lymphocytes recognize the neuraminidase glycoprotein of influenza virus subtype N1.

M Wysocka1, C J Hackett.   

Abstract

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes (CTL) that recognize the neuraminidase (NA) glycoprotein of subtype N1 influenza A viruses have been demonstrated in BALB/c mice. Responses to NA were obtained only in protocols that use two in vivo inoculations of virus, including a recombinant vaccinia virus containing the NA of subtype N1 influenza virus (NA-VAC) to prime or boost. Restimulation in vitro was also required for CTL recognition of NA and strongly depended on the specific N1 virus used. Influenza viruses A/Puerto Rico/8/34 (H1N1), A/CAM/46 (H1N1), J1 (H3N1), and JAP/BEL (H2N1), but not A/Bellamy (H1N1) or MEM/BEL (H3N1) virus, were able to stimulate NA-specific memory T cells in vitro. Single or double in vivo inoculation of any of the N1 viruses or a single injection of NA-VAC failed to elicit restimulatable NA-specific CTL. Lysis of NA-VAC-infected cells at low effector/target ratios was comparable to that observed toward other influenza virus proteins known to be major targets of CTL in BALB/c mice, indicating that antigenic determinants of the subtype N1 NA molecule can be efficiently presented in the context of major histocompatibility complex class I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304137      PMCID: PMC249213     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo.

Authors:  P M Taylor; B A Askonas
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

Review 2.  T-cell recognition of influenza viral antigens.

Authors:  J R Lamb; A J McMichael; J B Rothbard
Journal:  Hum Immunol       Date:  1987-06       Impact factor: 2.850

Review 3.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.

Authors:  B E Johansson; T M Moran; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Specific recognition of influenza virus polymerase protein (PB1) by a murine cytotoxic T-cell clone.

Authors:  J M Bastin; A R Townsend; A J McMichael
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

7.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

8.  Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

Authors:  F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

9.  Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.

Authors:  F Gotch; A McMichael; G Smith; B Moss
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.

Authors:  L A Morrison; A E Lukacher; V L Braciale; D P Fan; T J Braciale
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  5 in total

1.  Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin.

Authors:  C E Hioe; N Dybdahl-Sissoko; M Philpott; V S Hinshaw
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus.

Authors:  C J Hackett; D Horowitz; M Wysocka; L C Eisenlohr
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.

Authors:  M R Castrucci; S Hou; P C Doherty; Y Kawaoka
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus.

Authors:  E J Hogervorst; L Schouls; J P Wagenaar; C J Boog; W J Spaan; J D van Embden; W van Eden
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 5.  Evolutionary pressures rendered by animal husbandry practices for avian influenza viruses to adapt to humans.

Authors:  Maristela Martins de Camargo; Alexandre Rodrigues Caetano; Isabel Kinney Ferreira de Miranda Santos
Journal:  iScience       Date:  2022-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.